NO20084863L - "Insulinotropic" peptidsyntese - Google Patents

"Insulinotropic" peptidsyntese

Info

Publication number
NO20084863L
NO20084863L NO20084863A NO20084863A NO20084863L NO 20084863 L NO20084863 L NO 20084863L NO 20084863 A NO20084863 A NO 20084863A NO 20084863 A NO20084863 A NO 20084863A NO 20084863 L NO20084863 L NO 20084863L
Authority
NO
Norway
Prior art keywords
fragments
phase
solid
solution
insulinotropic
Prior art date
Application number
NO20084863A
Other languages
English (en)
Norwegian (no)
Inventor
Christopher R Roberts
Lin Chen
Yeun-Kwei Han
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20084863L publication Critical patent/NO20084863L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20084863A 2006-06-23 2008-11-19 "Insulinotropic" peptidsyntese NO20084863L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81591906P 2006-06-23 2006-06-23
PCT/EP2007/056052 WO2007147816A1 (en) 2006-06-23 2007-06-19 Insulinotropic peptide synthesis

Publications (1)

Publication Number Publication Date
NO20084863L true NO20084863L (no) 2009-01-22

Family

ID=38596729

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084863A NO20084863L (no) 2006-06-23 2008-11-19 "Insulinotropic" peptidsyntese

Country Status (33)

Country Link
US (2) US20080004429A1 (hr)
EP (1) EP2035451B1 (hr)
JP (1) JP4537495B2 (hr)
KR (1) KR101087859B1 (hr)
CN (1) CN101563364B (hr)
AR (1) AR061604A1 (hr)
AT (1) ATE466881T1 (hr)
AU (1) AU2007263043B2 (hr)
BR (1) BRPI0713575A2 (hr)
CA (1) CA2654610C (hr)
CL (1) CL2007001835A1 (hr)
CR (1) CR10463A (hr)
CY (1) CY1110186T1 (hr)
DE (1) DE602007006310D1 (hr)
DK (1) DK2035451T3 (hr)
EC (1) ECSP088999A (hr)
ES (1) ES2341588T3 (hr)
HR (1) HRP20100302T1 (hr)
IL (1) IL195421A0 (hr)
MA (1) MA30530B1 (hr)
MX (1) MX2008015935A (hr)
MY (1) MY144608A (hr)
NO (1) NO20084863L (hr)
NZ (1) NZ573093A (hr)
PL (1) PL2035451T3 (hr)
PT (1) PT2035451E (hr)
RS (1) RS51281B (hr)
RU (1) RU2448978C2 (hr)
SI (1) SI2035451T1 (hr)
TW (1) TWI331155B (hr)
UA (1) UA96602C2 (hr)
WO (1) WO2007147816A1 (hr)
ZA (1) ZA200810072B (hr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5473925B2 (ja) 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
EP2222695A2 (en) * 2007-12-11 2010-09-01 F. Hoffmann-La Roche AG Insulinotropic peptide synthesis using solid and solution phase combination techniques
US20100317057A1 (en) * 2007-12-28 2010-12-16 Novo Nordisk A/S Semi-recombinant preparation of glp-1 analogues
US20100183876A1 (en) * 2008-12-23 2010-07-22 Hell Andre Process for the Preparation of a Peptide Powder Form
CN102414220A (zh) * 2009-05-01 2012-04-11 霍夫曼-拉罗奇有限公司 使用固相和液相组合技术的促胰岛素肽合成
US20110313131A1 (en) * 2010-06-21 2011-12-22 Christelle Carl Reversed phase hplc purification of a glp-1 analogue
US20120157382A1 (en) 2010-12-21 2012-06-21 Siegfried Krimmer Pharmaceutical glp-1 compositions having an improved release profile
WO2013086514A1 (en) * 2011-12-08 2013-06-13 Pentair Water Pool And Spa, Inc. Aquaculture pump system and method
CN104011064A (zh) 2011-12-29 2014-08-27 诺沃—诺迪斯克有限公司 包含非成蛋白质性的氨基酸的二肽
CN104936610A (zh) 2012-11-13 2015-09-23 益普生制药股份有限公司 Glp-1类似物的纯化方法
WO2014077801A1 (en) 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Purification process for preparing highly pure taspoglutide
GR20140100479A (el) * 2014-09-23 2016-05-05 Novetide, Ltd., Συνθεση λιραγλουτιδης
PL3704143T3 (pl) 2018-03-09 2024-04-15 Fresenius Kabi Ipsum S.R.L. Chemo-enzymatyczna synteza liraglutydu, semaglutydu i glp-1
WO2019170895A1 (en) 2018-03-09 2019-09-12 Enzypep B.V. Chemo-enzymatic synthesis of semaglutide, liraglutide and glp-1
US11396533B2 (en) 2018-10-09 2022-07-26 Fresenius Kabi Ipsum S.R.L. Process for the manufacture of GLP-1 analogues
TWI738260B (zh) 2019-03-25 2021-09-01 台灣神隆股份有限公司 純化利拉魯肽之方法
CN114401981A (zh) * 2019-06-18 2022-04-26 北京费森尤斯卡比医药有限公司 胰高血糖素制造方法
EP3753946A1 (en) 2019-06-18 2020-12-23 Fresenius Kabi iPSUM S.r.l. Improved process for the preparation of high purity glucagon
US20230406900A1 (en) * 2022-06-01 2023-12-21 Scinopharm Taiwan, Ltd. Process for preparing glucagon-like peptide-1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281335B1 (en) * 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
US5705483A (en) * 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
CA2218173A1 (en) * 1995-04-14 1996-10-17 The Administrators Of The Tulane Educational Fund Analogs of growth hormone-releasing factor
UA65549C2 (uk) * 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
CZ295889B6 (cs) * 1998-12-07 2005-11-16 Societe De Conseils De Recherches Et D'application Analogy GLP-1, mající arginin na pozicích 26 a 34, jejich použití a farmaceutické prostředky je obsahující
US6514500B1 (en) * 1999-10-15 2003-02-04 Conjuchem, Inc. Long lasting synthetic glucagon like peptide {GLP-!}
US7238671B2 (en) * 2001-10-18 2007-07-03 Bristol-Myers Squibb Company Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
EP1701970A2 (en) * 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Methods for recovering cleaved peptide from a support

Also Published As

Publication number Publication date
AR061604A1 (es) 2008-09-10
MA30530B1 (fr) 2009-06-01
US20110213082A1 (en) 2011-09-01
BRPI0713575A2 (pt) 2013-02-13
PT2035451E (pt) 2010-06-09
DK2035451T3 (da) 2010-06-07
HRP20100302T1 (hr) 2010-06-30
AU2007263043A1 (en) 2007-12-27
NZ573093A (en) 2012-01-12
WO2007147816A1 (en) 2007-12-27
DE602007006310D1 (hr) 2010-06-17
CY1110186T1 (el) 2015-01-14
AU2007263043B2 (en) 2012-11-29
JP2009541257A (ja) 2009-11-26
MY144608A (en) 2011-10-14
RU2009101969A (ru) 2010-07-27
ES2341588T3 (es) 2010-06-22
SI2035451T1 (sl) 2010-06-30
TWI331155B (en) 2010-10-01
MX2008015935A (es) 2009-01-13
KR101087859B1 (ko) 2011-11-30
CN101563364A (zh) 2009-10-21
CL2007001835A1 (es) 2008-03-14
PL2035451T3 (pl) 2010-08-31
ZA200810072B (en) 2009-12-30
KR20090023619A (ko) 2009-03-05
IL195421A0 (en) 2011-08-01
US20080004429A1 (en) 2008-01-03
CA2654610C (en) 2012-03-20
CA2654610A1 (en) 2007-12-27
EP2035451B1 (en) 2010-05-05
ATE466881T1 (de) 2010-05-15
CR10463A (es) 2009-02-26
RS51281B (sr) 2010-12-31
CN101563364B (zh) 2014-04-02
TW200811195A (en) 2008-03-01
RU2448978C2 (ru) 2012-04-27
JP4537495B2 (ja) 2010-09-01
EP2035451A1 (en) 2009-03-18
UA96602C2 (ru) 2011-11-25
ECSP088999A (es) 2009-01-30

Similar Documents

Publication Publication Date Title
NO20084863L (no) "Insulinotropic" peptidsyntese
MX2010006044A (es) Sintesis de peptidos insulinotropicos utilizando una combinacion de tecnicas en fase solida y en solucion.
RU2559320C2 (ru) Новые аналоги глюкагона
TWI666026B (zh) Ｗｔ１抗原胜肽結合疫苗
CN101379075B (zh) 类胰高血糖素肽的合成
Patil et al. Relaxin family peptides: structure–activity relationship studies
Burlina et al. In situ thioester formation for protein ligation using α-methylcysteine
KR102461744B1 (ko) 아미노 2산을 함유한 펩타이드 변형제
CN104470948A (zh) Gip-glp-1双激动剂化合物及方法
EP1958957A1 (en) Polypeptide comprising a knottin protein moiety
Williams et al. Solid‐phase Thiol–Ene lipidation of peptides for the synthesis of a potent CGRP receptor antagonist
PE20060816A1 (es) Proceso para la concentracion de anticuerpos y productos terapeuticos de los mismos
EP3692056A1 (en) A process for preparing a glucagon-like peptide
JP2013540793A (ja) デガレリクスおよびその中間体を製造する方法
JP2015523373A (ja) ｅＩＦ４Ｅを標的化するための細胞浸透性ペプチド
Monsó et al. Reverse thioether ligation route to multimeric peptide antigens
WO2010125079A3 (en) Insulinotropic peptide synthesis using solid and solution phase combination techniques
TW201012829A (en) Process for the synthesis of (Aib8,35)hGLP-1(7-36)-NH2
TWI300414B (en) Modified peptide yy and conjugates thereof
WO2007100358A3 (en) Convergent synthesis of proteins by kinetically controlled ligation
Conroy et al. Efficient use of the Dmab protecting group: applications for the solid-phase synthesis of N-linked glycopeptides
JP7254771B2 (ja) 長鎖ペプチドの製造方法
Dong et al. Toward Homogeneous Erythropoietin: Application of Metal‐Free Dethiylation in the Chemical Synthesis of the Ala79‐Arg166 Glycopeptide Domain
US10239914B2 (en) In-situ solvent recycling process for solid phase peptide synthesis at elevated temperatures
WO2018141146A1 (en) Total chemical synthesis of lasso peptide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application